AM1241 is primarily utilized in scientific research to study the endocannabinoid system and its interactions with cannabinoid receptors. It acts as a selective agonist for the CB2 receptor, making it a valuable tool for investigating the role of CB2 in immune response, inflammation, and pain management. Researchers use it to explore potential therapeutic applications in conditions such as chronic pain, neuroinflammation, and autoimmune disorders. Its specificity for CB2 receptors allows for targeted studies without significant interference from CB1 receptor activity, which is associated with psychoactive effects. This makes AM1241 a key compound in advancing understanding of CB2-mediated pathways and their implications in drug development.